PEAK Stock Recent News

Amid the robust demand for lab assets, Healthpeak (PEAK) receives entitlements for the development of an additional 1.3 million square feet of lab space at its Vantage Campus.

Healthpeak is undervalued and has the potential to trade at a higher multiple due to its high-quality characteristics. The decline in market price is primarily due to multiple contraction, not a decline in earnings power. The concentration of lab exposure in San Francisco is a concern, but the market may have priced it in too harshly.

Healthpeak (PEAK) is poised to gain from the robust demand for lab assets and rising senior citizens' healthcare expenditure. However, competition from peers and high interest rates are woes.

Healthpeak (PEAK) reported earnings 30 days ago. What's next for the stock?

One reader asked me to write an article on where to invest $10,000 in REITs right now and keep the share price between $10 and $20. So, here's my reply, with an article on five REITs trading under $20 per share. The importance of diversification and personal preferences in constructing a stock portfolio is emphasized.

Physicians Realty Trust recently announced an all-stock merger with Healthpeak. Both real estate investment trusts collect rent from hundreds of medical outpatient buildings, but laboratories generate a majority of Healthpeak's net operating income.

Healthpeak is teaming up with Physicians Realty in what is being billed as a merger of equals. Healthpeak was once among the largest and most diversified healthcare REITs, but it has since slimmed down.

The Dividend Aristocrats index is down 5.5% YTD, compared to a 10.5% gain for the S&P 500.

Healthpeak's (PEAK) posts stellar Q3 results on better-than-expected revenues. Same-store portfolio cash (adjusted) net operating income rises across the portfolio.

Healthpeak Properties and Physicians Realty Trust are joining forces. The transformational transaction will create a larger and healthier healthcare REIT.